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Abstract
Background: Gastrointestinal (GI) dysmotility and autonomic neuropathy are common problems
among diabetics with largely unknown aetiology. Many peptides are involved in the autonomic
nervous system regulating the GI tract. The aim of this study was to examine if concentrations of
oxytocin, cholecystokinin (CCK), gastrin and vasopressin in plasma differ between diabetics with
normal function and dysfunction in GI motility.
Methods: Nineteen patients with symptoms from the GI tract who had been examined with
gastric emptying scintigraphy, oesophageal manometry, and deep-breathing test were included.
They further received a fat-rich meal, after which blood samples were collected and plasma frozen
until analysed for hormonal concentrations.
Results: There was an increase in postprandial oxytocin plasma concentration in the group with
normal gastric emptying (p = 0.015) whereas subjects with delayed gastric emptying had no
increased oxytocin secretion (p = 0.114). Both CCK and gastrin levels increased after the meal,
with no differences between subjects with normal respective delayed gastric emptying. The
concentration of vasopressin did not increase after the meal. In patients with oesophageal
dysmotility the basal level of CCK tended to be higher (p = 0.051) and those with autonomic
neuropathy had a higher area under the curve (AUC) of gastrin compared to normal subjects (p =
0.007).
Conclusion: Reduced postprandial secretion of oxytocin was found in patients with delayed
gastric emptying, CCK secretion was increased in patients with oesophageal dysmotility, and
gastrin secretion was increased in patients with autonomic neuropathy. The findings suggest that
disturbed peptide secretion may be part of the pathophysiology of digestive complications in
diabetics.
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Background
Many diabetic patients exhibit gastrointestinal (GI) dys-
motility and autonomic neuropathy. Gastroparesis is the
most well-described of the GI abnormalities, but
oesophageal dysmotility is also common [1-3]. The aetiol-
ogy to the dysmotility is largely unknown. Vagal or auto-
nomic neuropathy, myopathy and damage to interstitial
cells of Cajal (ICCs) have been proposed [4-6], but other-
wise pathological findings have been sparse [7]. As many
peptide hormones are involved in the regulation of the GI
physiology, disturbed secretion of these peptides might
contribute to a dysfunction.
Oxytocin and its receptor have recently been reported to
be expressed in the GI tract [8,9]. Oxytocin is released in
response to a fatty meal [10], which stimulates gastric
emptying [11,12], and administration of a receptor antag-
onist during the meal delays the gastric emptying [13].
Cholecystokinin (CCK) and gastrin are released from
endocrine cells in the upper GI tract in response to food,
and they influence relaxation of the lower oesophageal
sphincter (LOS), gastric acid secretion, gastric emptying,
growth of gastric mucosa, contraction of the gallbladder,
pancreatic growth, enzyme secretion, and intestinal motil-
ity [14,15]. Earlier studies have reported increased CCK
and gastrin concentrations in plasma from diabetics with
autonomic neuropathy [16-20], whereas patients without
neuropathy showed normal concentrations, irrespective
of GI function [17,19-21]. Recently, receptors for vaso-
pressin, a peptide hormone homologous to oxytocin,
have also been found in the GI tract [22], and vasopressin
has been shown to affect the electrical rhythm in the
human stomach [23,24].
Although both oxytocin, CCK, gastrin, and vasopressin
are involved in postprandial release and motility, the
plasma concentrations of these hormones have not been
thoroughly examined in relation to dysfunction in GI
motility or autonomic neuropathy. The aim of the present
study was therefore to examine whether the concentra-
tions in plasma of these hormones from patients suffering
from diabetes mellitus and GI symptoms are related to
abnormalities in gastric emptying, oesophageal motility,
and autonomic nerve function.
Methods
This study was performed according to the Helsinki decla-
ration and approved by the Ethics Committee of Lund
University. All patients were given written informed con-
sent before entering the study.
Subjects
Consecutive patients at the Diabetes Clinic at Malmö Uni-
versity Hospital, who complained of symptoms from the
digestive tract and were supposed to have gastroparesis,
were invited to gastric emptying scintigraphy, oesopha-
geal manometry, deep-breathing test reflecting the auto-
nomic nerve function and continuous subcutaneous
glucose concentration for 72 h. Patients with regular use
of opiates and other drugs influencing GI motility or hor-
monal release, or a marked reduced renal function were
excluded. In addition, patients with severe retinopathy
were excluded as some examinations demanded good
eyesight. Twenty patients (10 women) with stable meta-
bolic control accepted to participate [25].
Basal examination procedure
Gastric emptying scintigraphy was performed with the
subjects in a semi-recumbent position as earlier described.
A test meal was prepared by adding 30–50 Mbq of techne-
tium-99-labelled tin colloid to an egg, which was
whipped in a glass cup while being heated in a water bath
until coagulated. The scintigraphy half time (T50) was
identified from the point at which this tendency line
crossed the 50% value. Measurements of radionuclide
were corrected for decay according to Collins et al. [26].
T50 > 2 standard deviation (SD) of healthy controls (= 70
minutes) was considered abnormal [27].
Patients who fulfilled one or more pathological values in
the oesophageal manometry of the following five criteria
were considered to suffer from oesophageal dysmotility:
1/Absence of peristaltic contraction in the oesophagus, 2/
Mean peristaltic contraction amplitude < 30 or > 200 mm
Hg in the oesophagus, 3/Percentage of simultaneous,
non-propulsive peristaltic waves in the oesophagus > 10,
4/Speed of the peristaltic wave < 3 or > 6 cm/sec in the dis-
tal oesophagus, 5/Resting pressure in the LOS < 10 or > 30
mm Hg. Normal peristaltic activity was defined as propul-
sive contraction waves with peak amplitudes between 30–
200 mmHg and a speed between 3–6 cm/sec [28].
The expiratory/inspiratory (E/I) ratio was calculated from
the mean value of the longest R-R interval during expira-
tion and the shortest R-R interval during inspiration. This
is an established test of vagal, parasympathetic nerve func-
tion [29]. All test results were expressed in age-related val-
ues and an age-related value below -1.64 SD was
considered abnormal [30].
Patient characteristics
Out of the 20 patients included, 19 were further included
in the present study. All patients were insulin-treated; 17
with type 1 and 2 with type 2 diabetes. The 19 patients
were investigated with gastric emptying scintigraphy, 17
with a deep-breathing test and 13 with oesophageal man-
ometry. The reason that not all the patients performed all
the examinations, depended on that the patients had to
perform several different examinations, and thought it
was too much to go through everything. Ten of 19 patientsBMC Gastroenterology 2009, 9:17 http://www.biomedcentral.com/1471-230X/9/17
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had delayed gastric emptying (221 [116.0–362.5] min-
utes compared to 35.0 [23.5–44.5] minutes in patients
with normal emptying) and 7 out of 13 patients showed
dysmotility of the oesophagus in the form of aperistalsis
and/or simultaneous contractions. Nine of 17 showed
abnormal expiration/inspiration (E/I) quote as a sign of
autonomic neuropathy. There were no correlations
between disturbances in GI or autonomic function (data
not shown). The distribution of the GI symptoms, which
did not differ between groups except for abdominal full-
ness which correlated to delayed emptying, are presented
in an earlier study [25]. There was no difference in sex,
age, duration of diabetes, HbA1c or glucose levels
between the groups of normal and abnormal function of
respective parameter [25].
When scrutinizing the medical records, one was found to
suffer from pernicious anaemia, whereas all the others
had normal values of haemoglobin and cobalamines.
Experimental procedure
All subjects were fasted overnight. In the morning they
were given a fat-rich meal containing 150 g cream and 150
g water. This generated 60 g fat and 561 kcal. This meal
corresponds to the same content of fat as earlier used to
evoke CCK and oxytocin secretion [10]. Blood samples
were taken through an intravenous catheter 10 min and
immediately before the meal, as well as 10, 20, 30, 45, 60,
90, 120, 150 and 180 min after the meal. All blood sam-
ples consisted of 8.0 ml whole blood drawn into iced
heparinised tubes. The plasma was separated and frozen
at -20°C immediate after the experiment.
Plasma analyses
Oxytocin
Oxytocin levels were determined using Correlate-EIA™
Oxytocin Enzyme Immunoassay Kit (Assay designs, Inc.
Ann Arbor, USA) according to the instructions from the
manufacturer. Included on each plate were standards and
controls as recommended. Plasma samples were diluted
five times in assay buffer before analysis. The washing pro-
cedure was performed using an Anthos Fluido micro plate
washer (Anthos Fluido, Salzburg, Austria) and the absorb-
ance was read using a Multiscan (R) Ex micro plate pho-
tometer (Thermo Electron Corporation, Vantaa, Finland).
The colour development of the samples was read at 405
nm with background correction at 620 nm. The Ascent
software was used for creation of standard curves, curve
fitting and calculation of concentrations (Ascent software
version 2.6 for iEMS Reader MF and multiscan, Vantaa,
Finland).
Cholecystokinin (CCK) and gastrin
The concentrations of CCK in plasma were measured
using a highly accurate radioimmunoassay, as previously
described [31]. The limit of detection for this assay is 0.1
pmol/l with intra-assay and interassay variations of less
than 5% and 15%, respectively, at both 3.7 and 15 pmol/
l concentrations. The concentration of gastrin in plasma
was also assayed by radioimmunoassay using rabbit anti-
body 2604–8 [32] and 125I-iodinated human gastrin-17 as
tracer [33]. The detection limit was 5 pg/ml and the inte-
rassay coefficient of variation was below 8% in the range
10–100 pg/ml.
Vasopressin
The concentration of vasopressin in plasma was analyzed
by a radioimmunoassay described by Rooke & Baylis [34].
Statistical analyses
The concentrations are given as median [interquartile
ranges, IQR]. The basal value is the mean of the two sam-
ples taken before the meal. Peak value is the highest con-
centration measured in plasma after the meal. The area
under the curve (AUC) was calculated for oxytocin, CCK
and gastrin from all samples taken. The Mann-Whitney U
test was used for comparisons between groups and the
Wilcoxon signed test for comparisons between basal and
peak levels within the group. The Spearman test was used
for correlations between different parameters. P < 0.05
was considered statistical significant.
Results
Hormone concentrations in plasma in relation to gastric 
emptying
There was a significant increase in postprandial oxytocin
concentrations as compared to baseline in the group of
patients with normal gastric emptying. In contrast,
patients with delayed gastric emptying showed no
increase of oxytocin secretion in response to the meal (Fig
1). However, the AUC did not differ between the two
groups (16952.7 [8396.3–44792.2] and 37425.1
[14724.6–63779.9], respectively; p = 0.400), as did either
basal or peak values (Fig 1). The oxytocin concentration in
plasma in the two groups over time is shown in Fig 2. CCK
and gastrin secretions were both increased compared to
baseline in response to the meal. There were no differ-
ences in the secretion of these hormones between patients
with normal versus delayed gastric emptying (Fig 3 and
4). The plasma concentration of vasopressin was not
increased after the meal between patients with normal
gastric emptying (0.7 [0.5–0.8] during basal conditions
compared to 0.6 [0.5–1.0] pmol/l postprandial; p =
0.285), why this hormone was not studied in subjects
with delayed gastric emptying. There were no significant
correlations between the plasma concentrations of the dif-
ferent hormones (data not shown).BMC Gastroenterology 2009, 9:17 http://www.biomedcentral.com/1471-230X/9/17
Page 4 of 9
(page number not for citation purposes)
Hormone concentrations in plasma in relation to 
oesophageal dysmotility
The basal concentrations of CCK tended to be higher in
the group of patients with aperistalsis and/or simultane-
ous contractions compared to those with normal
oesophageal motility (Fig 5), whereas there was no differ-
ence in the peak concentrations measured after the meal
(3.6 [2.8–5.3] and 3.4 [2.6–8.6] pmol/l, respectively; p =
0.604), nor in the AUC (377.8 [257.8–548.0] and 273.0
[230.6–419.2], respectively; p = 0.366).
The LOS pressure correlated negatively to the CCK con-
centrations (rs = -0.679, p = 0.022). None of the other hor-
mones correlated with the oesophageal function (data not
shown).
Hormone concentrations in plasma in relation to 
autonomic neuropathy
Patients with autonomic neuropathy had significantly
higher concentrations of gastrin in plasma than patients
without neuropathy. There were differences both in the
The plasma concentration of oxytocin (oxy) at basal conditions and peakpostprandially, in subjects with and without gas- troparesis Figure 1
The plasma concentration of oxytocin (oxy) at basal conditions and peakpostprandially, in subjects with and 
without gastroparesis. The basal value is the mean of the two samples taken before the meal. Peak value is the highest level 
measured in plasma after the meal. Median [IQR]. Wilcoxon signed test. There was no difference in basal or peak values 
between the groups, Mann-Whitney U-test.
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The fluctuations of the mean oxytocin concentration in  plasma postprandial, in subjects with and without gastropare- sis Figure 2
The fluctuations of the mean oxytocin concentration 
in plasma postprandial, in subjects with and without 
gastroparesis. GP = gastroparesis, n = 10, no gastroparesis, 
n = 9. There was no statistical significant difference between 
the groups. Mann Whitney U-test.
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AUC (Fig 6) and the peak values (22.0 [15.5–57.0] and
13.5 [11.2–15.0] pmol/l, respectively; p = 0.046). There
were no differences in oxytocin or CCK peak concentra-
tions between the groups (181.5 [73.6–449.5] and 211.4
[139.7–346.8] pg/ml oxytocin, respectively; p = 0.888;
and 4.4 [3.3–6.6] and 3.4 [2.8–5.6] pmol/l CCK, respec-
tively; p = 0.423). Neither was there any difference in the
AUC between those with or without autonomic neuropa-
thy (29502.5 [9377.3–65353.4] and 30536.7 [10605.1–
56321.3] for oxytocin, respectively; p = 0.743; and 423.0
[274.2–661.0] and 305.1 [258.4–369.0] for CCK, respec-
tively; p = 0.195).
Discussion
This is the first study to show that patients with diabetes
mellitus and normal gastric emptying rate have an
increased release of oxytocin postprandially, whereas
patients with delayed gastric emptying rate have no such
increased postprandial secretion. Instead, patients with
delayed gastric emptying tended to have a decrease in oxy-
tocin concentrations with less fluctuation over time. There
was no difference in CCK or gastrin secretion related to
gastric emptying, but patients with oesophageal dysmotil-
ity tended to have higher basal CCK concentrations, and
in autonomic neuropathy gastrin concentrations were
increased compared to normal subjects.
Oxytocin was long thought to be a hormone primarily
involved in parturition and suckling. We now know that
oxytocin has diverse effects throughout the human body,
for example on the release of atrial natriuretic peptide and
in endothelial and smooth muscle cells in blood vessels
[35,36]. In normal subjects, oxytocin expression has been
found in the gut [8,9], where it is secreted after a meal [10]
and stimulates colonic activity [37]. It has further been
demonstrated that systemic administration of oxytocin
leads to enhanced gastric emptying [11,12] and that the
oxytocin receptor antagonist atosiban delays gastric emp-
tying significantly [13]. The prokinetic effect of oxytocin
on the gut has been assumed to be similar to the one in
uterine myometrium and mammary myoepitheal cells;
i.e. intracellular release of Ca2+ which leads to muscle
contraction via myosin light kinase activity [38].
The plasma concentration of cholecystokinin (CCK) at basal conditions and peakpostprandially, in subjects with and without  gastroparesis Figure 3
The plasma concentration of cholecystokinin (CCK) at basal conditions and peakpostprandially, in subjects 
with and without gastroparesis. The basal value is the mean of the two samples taken before the meal. Peak value is the 
highest level measured in plasma after the meal. Median [IQR]. Wilcoxon signed test. There was no difference in basal or peak 
values between the groups, Mann-Whitney U-test.
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Oxytocin concentrations were higher in this study than in
earlier studies [10]. This depends on that ELIZA in general
give higher values than radioimmunoasays (RIA). The two
peaks in oxytocin secretion in diabetics without gas-
troparesis are similar to those seen in healthy subjects
after a meal [10]. This could be explained by a rapid
release of oxytocin from the gut and a later one from the
hypophysis. The oxytocin release from the hypophysis is
due to an effect of CCK on afferent vagal nerves and
appears with some time delay after that the meal has
induced CCK secretion [10,39]. This hypothesis is
strengthened by the fact that this dual oxytocin release
was not seen after intravenous CCK injection [10,40]. The
reduced postprandial oxytocin secretion in subjects with
delayed gastric emptying could be part of the pathogene-
sis in gastroparesis. It is still unknown whether this distur-
bance is primary or secondary to gastroparesis or depends
on dysfunction in the CCK-oxytocin interaction, intrinsic
gastric nerves, the vagal nerve, or in regulation of other
hormones. Nevertheless, a substitution with oxytocin
postprandially may regain the gastric dysfunction and
should be tested.
Cholecystokinin is produced in endocrine I-cells in the
upper part of the small intestine and has an important
role in relaxation of the LOS and gastric emptying [14].
The oesophageal dysmotilities in patients in this study
were aperistalsis and simultaneous contractions [25]. We
do not know why they are associated with hyperCCK-
emia. It may be due to abnormal neural reflexes affecting
the CCK release, or to concomitant small intestinal dys-
motility delaying the clearing of nutrients from the small
intestine with ensuing increase in CCK secretion [41]. In
our earlier study we saw that patients with oesophageal
dysmotility also had delayed blood glucose response after
a meal [25], a finding in agreement with this discussion.
In a previous study Glasbrenner [19] found CCK to be ele-
vated in plasma from patients with autonomic neuropa-
thy. Another study showed significantly lower CCK
concentrations in diabetics without autonomic neuropa-
thy compared to healthy controls [42]. It is possible that
the patients in Glasbrenner's study [19] with hyperCCK-
emia also suffered from oesophageal dysmotility, which
could explain their results.
Gastrin is released in response to food intake and acts in
the stomach by stimulation of acid secretion and mucosal
growth [15]. This process is regulated by a negative feed-
back mechanism to prevent excessive acid secretion. In
The plasma concentration of gastrin at basal conditions and postprandially, in subjects with and without gastroparesis Figure 4
The plasma concentration of gastrin at basal conditions and postprandially, in subjects with and without gas-
troparesis. The basal value is the mean of the two samples taken before the meal. Peak value is the highest level measured in 
plasma after the meal. Median [IQR]. Wilcoxon signed test. There was no difference in basal or peak values between the 
groups, Mann-Whitney U-test.
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accordance with earlier studies we found that patients
with autonomic neuropathy have significantly higher
concentrations of gastrin in plasma [16-18,20]. The ele-
vated gastrin concentrations cannot be explained by
atrophic gastritis in this study since only one subject had
this condition. However, the elevation could be a result of
a disturbed feedback mechanism due to neuropathy in the
stomach [6], vagal neuropathy [16,17], an increased
quantity of gastrin cells in the stomach [43], reduced
number of somatostatin cells [44], or hyperglycaemia
[45].
Vasopressin is homologous to oxytocin. Recently it has
been shown that the vasopressin receptor is expressed
throughout the GI tract [22]. We measured the concentra-
tion of vasopressin after a meal in patients with normal
gastric emptying and found no increased secretion com-
pared to basal conditions. As vasopressin thus not seems
to be an important peptide in relation to a meal, we
decided not to measure vasopressin in the rest of the
patients.
Conclusion
We have shown that patients with diabetes mellitus and
normal gastric emptying have a postprandial increase in
oxytocin secretion, whereas oxytocin secretion is impaired
in subjects with delayed gastric emptying. We could not
find a difference in postprandial CCK or gastrin secretion
in patients with and without delayed gastric emptying.
However, in patients with oesophageal dysmotility the
basal concentration of CCK tended to be higher, and in
patients with autonomic neuropathy the gastrin concen-
trations were increased compared to normal subjects. In
the light of our earlier research on oxytocin and its role for
a normal GI function [11,12,33-37], the role of oxytocin
treatment in gastroparesis has to be further evaluated.
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